Análise da eficácia do uso de cloridrato de Lurasidona no tratamento da Esquizofrenia em adultos

• Autores: Nathany Martello Eich, Mirian Lopes Cavalcante, Daiani Alves Pereira, Tiffany Santos Menezes, José Virgulino de Oliveira Lima
• Localización: Cuadernos de Educación y Desarrollo, ISSN-e 1989-4155, Vol. 16, Nº. Extra 2, 2024
• Idioma: inglés
• DOI: 10.55905/cuadv16n2-ed.esp.163
• Enlaces
  • Texto completo
• Resumen

  • O cloridrato de lurasidona é um antipsicótico de 2ª geração, aprovado em 2022 pela Agência Nacional de Vigilância Sanitária, no Brasil, como novo tratamento de esquizofrenia e transtorno bipolar.

• Referencias bibliográficas
  • ALLEN, Michael H et al. Efficacy of lurasidone in the treatment of agitation: A post hoc analysis of five short-term studies in acutely ill...
  • CALISTI, Fabrizio et al. Efficacy and safety of lurasidone in schizophrenia: pooled analysis of European results from double-blind, placebo-controlled...
  • LOEBEL, Antony et al. Treatment of early non-response in patients with schizophrenia: assessing the efficacy of antipsychotic dose escalation....
  • NASRALLA, Henry A et al. Lurasidone for the treatment of acutely psychotic patients with schizophrenia: a 6-week, randomized, placebo-controlled...
  • STAHL, Stephen M et al. Effectiveness of lurasidone for patients with schizophrenia following 6 weeks of acute treatment with lurasidone,...